Journal Article

FZJ-2024-03596

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Advanced Imaging in the Diagnosis and Response Assessment of High-Grade Glioma: AJR Expert Panel Narrative Review

Hu, L. S. (Corresponding author) ; Smits, M. ; Kaufmann, T. J. ; Knutsson, L. ; Rapalino, O. ; Galldiks, N.FZJ* ; Sundgrene, P. C. ; Cha, S.

2025
American Roentgen Ray Society Leesburg, Va.

This record in other databases:  

Please use a persistent id in citations: doi:10.2214/AJR.23.30612

Abstract: This AJR Expert Panel Narrative Review explores the current status of advanced MRI and PET techniques for the posttherapeutic response assessment of high-grade adult-type gliomas, focusing on ongoing clinical controversies in current practice. Discussed techniques that complement conventional MRI and aid the differentiation of recurrent tumor from posttreatment effects include DWI and diffusion-tensor imaging; perfusion MRI techniques including dynamic susceptibility contrast (DSC), dynamic contrast-enhanced, and arterial spin labeling MRI; MR spectroscopy (MRS) including assessment of 2-hydroxyglutarate (2HG) concentration; glucose- and amino acid (AA)-based PET; and amide proton transfer imaging. Updated criteria for the Response Assessment in Neuro-Oncology are presented. Given the abundant supporting clinical evidence, the panel supports a recommendation that routine response assessment after high-grade glioma treatment should include perfusion MRI, particularly given the development of a consensus recommended DSC-MRI protocol. Although published studies support 2HG MRS and AA PET, these techniques' widespread adoption will likely require increased availability (for 2HG MRS) or increased insurance funding in the United States (for AA PET). The review concludes with a series of consensus opinions from the author panel, centered on the clinical integration of the advanced imaging techniques into posttreatment surveillance protocols.Keywords: PET; advanced MRI; high-grade glioma; posttreatment; surveillance.

Note: Supported by NIH grants to L. S. Hu (nos.U01CA220378, U01CA250481,R01CA264992, R01CA221938, and R21NS082609).

---

Contributing Institute(s):

1. Kognitive Neurowissenschaften (INM-3)

Research Program(s):

1. 5252 - Brain Dysfunction and Plasticity (POF4-525) (POF4-525)

Appears in the scientific report 2025

---

Database coverage:
; ; Clarivate Analytics Master Journal List ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Current Contents - Life Sciences ; Essential Science Indicators ; Essential Science Indicators ; IF >= 5 ; IF >= 5 ; JCR ; JCR ; SCOPUS ; SCOPUS ; Science Citation Index Expanded ; Science Citation Index Expanded ; Web of Science Core Collection ; Web of Science Core Collection

---